[Membrane effects of insulin in x-chromosome recessive hereditary progressive muscular dystrophy (Duchenne form)].
D000704:Analysis of Variance; D001219:Aspartate Aminotransferases / Q000097:blood; D002463:Cell Membrane Permeability / Q000187:drug effects*; D002648:Child; D003401:Creatine / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D003864:Depression, Chemical; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D005808:Genes, Recessive; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D009136:Muscular Dystrophies / Q000235:genetics / Q000378:metabolism*; D010758:Phosphorus / Q000097:blood; D011188:Potassium / Q000097:blood; D014176:Protein Biosynthesis; D012730:Sex Chromosomes; D012964:Sodium / Q000097:blood
D007328:Insulin; D010758:Phosphorus; D012964:Sodium; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase; D005947:Glucose; D003401:Creatine; D011188:Potassium
Membranwirkungen des Insulins bei x-chromosomal recessiv erblicher progressiver Muskeldystrophie (Typ Duchenne)